Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Pituitary gland tumors].

W Saeger1

  • 1Institut für Pathologie des Marienkrankenhauses, Hamburg. WolfgangSaeger.HH@t-online.de

Der Pathologe
|September 27, 2003
PubMed
Summary

Accurate pituitary adenoma sub-classification is crucial for treatment planning, especially when differentiating from other sellar tumors. Immunohistochemistry and special staining techniques aid in precise tumor typing and guiding therapy decisions.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Novel AIP mutation in exon 6 causing acromegaly in a German family.

Journal of endocrinological investigation·2023
Same author

Typing of inflammatory lesions of the pituitary.

Pituitary·2021
Same author

Adrenal cancer: relevance of different grading systems and subtypes.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico·2021
Same author

A standardised diagnostic approach to pituitary neuroendocrine tumours (PitNETs): a European Pituitary Pathology Group (EPPG) proposal.

Virchows Archiv : an international journal of pathology·2019
Same author

[Tumors of the adrenal glands : Update].

Der Pathologe·2019
Same author

[Ectopic tissue].

Der Pathologe·2018

Area of Science:

  • Endocrinology
  • Surgical Pathology
  • Neurosurgery

Background:

  • Pituitary adenomas require differentiation from similar sellar region tumors like meningiomas.
  • Accurate sub-classification of pituitary adenomas is essential for effective treatment strategies.

Purpose of the Study:

  • To detail the methods for differentiating pituitary adenomas from other sellar tumors.
  • To outline the sub-classification of pituitary adenomas based on hormonal expression and morphology.

Main Methods:

  • Immunohistochemistry for pituitary hormones.
  • Special staining techniques for identifying adenoma subtypes.
  • Morphological analysis of tumor structures.

Main Results:

  • Differentiated monohormonal and bihormonal adenomas based on hormone expression.
  • Identified subtypes including GH-cell, prolactin cell, ACTH-cell, TSH-cell, and FSH/LH cell adenomas.
  • Classified clinically inactive adenomas (null cell, oncocytic, FSH/LH-cell) as gonadotroph cell subtypes.
  • Distinguished adamantinous and papillary craniopharyngiomas.

Conclusions:

  • Accurate sub-classification of pituitary adenomas is vital, particularly when surgery is unsuccessful or further treatment is planned.
  • Immunohistochemistry and special stains are indispensable tools for precise pituitary adenoma typing.
  • Distinguishing between pituitary adenoma subtypes and other sellar tumors ensures appropriate clinical management.

Related Experiment Videos